Skip Navigation

OncoTheis Wins 2015 Lush Science Prize for In Vitro Cancer Modeling

OncoTheis has won the prestigious 2015 Lush Science Prize for its OncoCilAir™project.

OncoCilAir™ is a unique in vitro human lung-cancer modelthat recapitulates tumor growth in functional airway tissue. OncoCilAir™ allows testing drug efficacy and side-toxicity, drug resistance, and tumor recurrence.

OncoTheis is a Swiss biotech company dedicated to developing innovative bioengineered tissues and organoids for cancer research. The have produced a new generation of integrated 3D in vitro models that combine both healthy and cancerous tissues in order to accurately simulate in vivo situation. Such models are intended to increase the quality of preclinical research while reducing animal testing.

Since 2014, OncoTheis has received several prizes recognizing its involvement in the development of reliable in vitro alternatives to animal experimentation, including the Egon Naëf Foundation prize, the EthicScience award and now, the Lush Science Prize.

New ALTEX: 4/2017
ALTEX 3/2017 cover

Support ALTWEB, Make a Gift
Online Humane Science Course


Progress in Refinement: Enhancement of Scientific Integrity and Animal Well-Being
November 30, 2107

GIVIMP and Quality Procedures for the EU-ToxRisk Project (Webinar)
December 1, 2017
Details TBA


Advances in Cell and Tissue Culture
May 21-23, 2018
Cardiff University, UK
2nd Pan-American Conference for Alternative Methods
August 23-24, 2018
Rio de Janeiro, Brazil 

More Meetings...